Literature DB >> 7073342

Scleroderma and erosive polyarthritis: a disease entity?

R D Armstrong, T Gibson.   

Abstract

We describe 4 patients with scleroderma in whom a major clinical feature was a deforming, erosive polyarthritis accompanied by positive tests for rheumatoid factor. In all but 1 case the skin involvement preceded joint symptoms, and in some cases there was evidence of systemic involvement. This destructive arthritis may represent the coexistence of 2 diseases or an extreme form of the inflammatory arthritis seen in scleroderma. Alternatively, the clinical presentation may represent an 'overlap syndrome' with features of both scleroderma and rheumatoid arthritis.

Entities:  

Mesh:

Year:  1982        PMID: 7073342      PMCID: PMC1000898          DOI: 10.1136/ard.41.2.141

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  20 in total

1.  Erosive arthropathy in systemic scleroderma.

Authors:  W Wild; W P Beetham
Journal:  JAMA       Date:  1975-05-05       Impact factor: 56.272

2.  Mixed connective tissue disease--clinical and radiological aspects of 20 cases.

Authors:  D J O'Connell; R M Bennett
Journal:  Br J Radiol       Date:  1977-09       Impact factor: 3.039

Review 3.  Systemic scleroderma: A review of organ systems.

Authors:  R R Kinder; R Fleischmajer
Journal:  Int J Dermatol       Date:  1974 Nov-Dec       Impact factor: 2.736

4.  Similar bone manifestations of scleroderma and rheumatoid arthritis.

Authors:  J G Rabinowitz; J Twersky; M Guttadauria
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1974-05

5.  Synovial tissue changes and rheumatoid factor in scleroderma.

Authors:  J A Clark; R K Winkelmann; F C McDuffie; L E Ward
Journal:  Mayo Clin Proc       Date:  1971-02       Impact factor: 7.616

6.  Progressive systemic sclerosis.

Authors:  R A Harper; D C Jackson
Journal:  Br J Radiol       Date:  1965-11       Impact factor: 3.039

7.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

Authors:  G C Sharp; W S Irvin; E M Tan; R G Gould; H R Holman
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

8.  Clinical features of the arthritis of mixed connective tissue disease.

Authors:  J T Halla; J G Hardin
Journal:  Arthritis Rheum       Date:  1978-06

Review 9.  The rheumatic manifestaions of progressive systemic sclerosis (scleroderma).

Authors:  G P Rodnan; T A Medsger
Journal:  Clin Orthop Relat Res       Date:  1968 Mar-Apr       Impact factor: 4.176

10.  Uracil-specific anti-R.N.A. antibodies in scleroderma.

Authors:  D Alarcón-Segovia; E Fishbein; E García-Ortigoza; S Estrada-Parra
Journal:  Lancet       Date:  1975-02-15       Impact factor: 79.321

View more
  4 in total

1.  Knee contractures as the presenting manifestation of scleroderma.

Authors:  G Kane-Wanger; B E Ostrov; B Freundlich
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

2.  Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis.

Authors:  Francesca Ingegnoli; Valentina Galbiati; Silvana Zeni; Laura Meani; Lenka Zahalkova; Chiara Lubatti; Amedeo Soldi; Erberto Paresce; Antonella Murgo; Calogero Crapanzano; Flavio Fantini
Journal:  Clin Rheumatol       Date:  2006-05-03       Impact factor: 2.980

3.  Unusual articular abnormalities in scleroderma.

Authors:  J Albert; H Ott
Journal:  Clin Rheumatol       Date:  1984-09       Impact factor: 2.980

4.  The arthropathy of systemic sclerosis: a 12 month prospective clinical and imaging study.

Authors:  Giovanni La Montagna; Antonio Sodano; Vittorio Capurro; Domenico Malesci; Gabriele Valentini
Journal:  Skeletal Radiol       Date:  2004-09-17       Impact factor: 2.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.